These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 26355510)

  • 41. Boolean network model for cancer pathways: predicting carcinogenesis and targeted therapy outcomes.
    Fumiã HF; Martins ML
    PLoS One; 2013; 8(7):e69008. PubMed ID: 23922675
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A pathology atlas of the human cancer transcriptome.
    Uhlen M; Zhang C; Lee S; Sjöstedt E; Fagerberg L; Bidkhori G; Benfeitas R; Arif M; Liu Z; Edfors F; Sanli K; von Feilitzen K; Oksvold P; Lundberg E; Hober S; Nilsson P; Mattsson J; Schwenk JM; Brunnström H; Glimelius B; Sjöblom T; Edqvist PH; Djureinovic D; Micke P; Lindskog C; Mardinoglu A; Ponten F
    Science; 2017 Aug; 357(6352):. PubMed ID: 28818916
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Data-Driven Modeling of Breast Cancer Tumors Using Boolean Networks.
    Sgariglia D; Conforte AJ; Pedreira CE; Vidal de Carvalho LA; Carneiro FRG; Carels N; Silva FABD
    Front Big Data; 2021; 4():656395. PubMed ID: 34746770
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantifying the notions of canalizing and master genes in a gene regulatory network-a Boolean network modeling perspective.
    Kim E; Ivanov I; Dougherty ER
    Bioinformatics; 2019 Feb; 35(4):643-649. PubMed ID: 30052771
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Controllability analysis of the directed human protein interaction network identifies disease genes and drug targets.
    Vinayagam A; Gibson TE; Lee HJ; Yilmazel B; Roesel C; Hu Y; Kwon Y; Sharma A; Liu YY; Perrimon N; Barabási AL
    Proc Natl Acad Sci U S A; 2016 May; 113(18):4976-81. PubMed ID: 27091990
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The power of boolean implication networks.
    Sahoo D
    Front Physiol; 2012; 3():276. PubMed ID: 22934030
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Resilience function uncovers the critical transitions in cancer initiation.
    Li Y; Zhang SW
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 33954583
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Weak Stabilization of Boolean Networks Under State-Flipped Control.
    Liu Z; Zhong J; Liu Y; Gui W
    IEEE Trans Neural Netw Learn Syst; 2023 May; 34(5):2693-2700. PubMed ID: 34499607
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Controllability analysis of molecular pathways points to proteins that control the entire interaction network.
    Devkota P; Wuchty S
    Sci Rep; 2020 Feb; 10(1):2943. PubMed ID: 32076007
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Network Rewiring in Cancer: Applications to Melanoma Cell Lines and the Cancer Genome Atlas Patients.
    Ding KF; Finlay D; Yin H; Hendricks WPD; Sereduk C; Kiefer J; Sekulic A; LoRusso PM; Vuori K; Trent JM; Schork NJ
    Front Genet; 2018; 9():228. PubMed ID: 30042785
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Normalizing Input-Output Relationships of Cancer Networks for Reversion Therapy.
    Joo JI; Park HJ; Cho KH
    Adv Sci (Weinh); 2023 Aug; 10(24):e2207322. PubMed ID: 37269056
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biological functions of the genes in the mammaprint breast cancer profile reflect the hallmarks of cancer.
    Tian S; Roepman P; Van't Veer LJ; Bernards R; de Snoo F; Glas AM
    Biomark Insights; 2010 Nov; 5():129-38. PubMed ID: 21151591
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Near-Optimal Control Method for Stochastic Boolean Networks.
    Aguilar B; Fang P; Laubenbacher R; Murrugarra D
    Lett Biomath; 2020 May; 7(1):67-80. PubMed ID: 34141873
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cancer and genes: how will molecular biology reshape our clinical practice?
    Ponder BA
    Neth J Med; 1997 May; 50(5):211-5. PubMed ID: 9175402
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The structural basis for cancer treatment decisions.
    Nussinov R; Jang H; Tsai CJ
    Oncotarget; 2014 Sep; 5(17):7285-302. PubMed ID: 25277176
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficient computation of minimal perturbation sets in gene regulatory networks.
    Garg A; Mohanram K; Di Cara A; Degueurce G; Ibberson M; Dorier J; Xenarios I
    Front Physiol; 2013; 4():361. PubMed ID: 24391592
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thirteenth annual pezcoller symposium: focusing analytical tools on complexity in cancer.
    Mihich E; Feunteun J; Friend S
    Cancer Res; 2002 Jul; 62(13):3883-7. PubMed ID: 12097304
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recovery from stress - a cell cycle perspective.
    Radmaneshfar E; Thiel M
    J Comput Interdiscip Sci; 2012 Oct; 3(1-2):33-44. PubMed ID: 24729835
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cancer (r)evolution.
    von Loga K; Gerlinger M
    Nat Ecol Evol; 2017 Aug; 1(8):1051-1052. PubMed ID: 29046586
    [No Abstract]   [Full Text] [Related]  

  • 60. Cancer Molecular Evolution.
    Posada D
    J Mol Evol; 2015 Oct; 81(3-4):81-3. PubMed ID: 26289731
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.